ATE222601T1 - Methode zur expression in und isolation von biologisch aktiven molekülen aus urin - Google Patents
Methode zur expression in und isolation von biologisch aktiven molekülen aus urinInfo
- Publication number
- ATE222601T1 ATE222601T1 AT96916890T AT96916890T ATE222601T1 AT E222601 T1 ATE222601 T1 AT E222601T1 AT 96916890 T AT96916890 T AT 96916890T AT 96916890 T AT96916890 T AT 96916890T AT E222601 T1 ATE222601 T1 AT E222601T1
- Authority
- AT
- Austria
- Prior art keywords
- expression
- urine
- isolation
- biologically active
- active molecules
- Prior art date
Links
- 238000002955 isolation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 210000002700 urine Anatomy 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000013532 Uroplakin II Human genes 0.000 abstract 2
- 108010065940 Uroplakin II Proteins 0.000 abstract 2
- 101000808106 Mus musculus Uroplakin-2 Proteins 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 238000011830 transgenic mouse model Methods 0.000 abstract 1
- 210000003741 urothelium Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Plant Pathology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Husbandry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/464,961 US5824543A (en) | 1995-06-05 | 1995-06-05 | Method for expression and isolation of biologically active molecules in urine using a mouse uroplakin-II promoter |
PCT/US1996/008233 WO1996039494A1 (en) | 1995-06-05 | 1996-05-31 | Method for expression and isolation of biologically active molecules in urine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE222601T1 true ATE222601T1 (de) | 2002-09-15 |
Family
ID=23845974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96916890T ATE222601T1 (de) | 1995-06-05 | 1996-05-31 | Methode zur expression in und isolation von biologisch aktiven molekülen aus urin |
Country Status (7)
Country | Link |
---|---|
US (2) | US5824543A (de) |
EP (1) | EP0837931B1 (de) |
AT (1) | ATE222601T1 (de) |
AU (1) | AU5961596A (de) |
CA (1) | CA2221453A1 (de) |
DE (1) | DE69623122T2 (de) |
WO (1) | WO1996039494A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7179611B2 (en) * | 1997-02-10 | 2007-02-20 | Bd Lee Laboratories | Mono-specific polyclonal antibodies and methods for detecting Clostridium difficile Toxin A |
US20020184655A1 (en) * | 1997-12-01 | 2002-12-05 | Henryk Lubon | Methods for the degradation and detoxification of organic material using urine produced by transgenic animals and related transgenic animals and proteins |
US7157615B2 (en) | 1998-03-17 | 2007-01-02 | Nexia Biotechnologies, Inc. | Production of biofilaments in transgenic animals |
AU5755399A (en) * | 1998-09-16 | 2000-04-03 | Nexia Biotechnologies, Inc. | Recombinant protein production in urine |
US6888047B1 (en) | 1998-11-13 | 2005-05-03 | New York University | Transgenic animals as urinary bioreactors for the production of polypeptide in the urine, recombinant DNA construct for kidney-specific expression, and method of using same |
ES2298127T3 (es) * | 1999-01-06 | 2008-05-16 | Merrimack Pharmaceuticals Inc | Expresion de alfa-fetoproteina secretada humana en animales transgenicos. |
US7048920B2 (en) * | 2000-03-24 | 2006-05-23 | Cell Genesys, Inc. | Recombinant oncolytic adenovirus for human melanoma |
EP1268761B1 (de) * | 2000-03-24 | 2008-12-31 | Cell Genesys, Inc. | Menschliche zellspezifische urotheliale regulatorische sequenzen der transkription des uroplakins, dessen vektoren und verwendungsverfahren |
US6692736B2 (en) | 2000-03-24 | 2004-02-17 | Cell Genesys, Inc. | Cell-specific adenovirus vectors comprising an internal ribosome entry site |
KR100552634B1 (ko) * | 2002-11-04 | 2006-02-20 | 조아제약주식회사 | 돼지의 유로플라킨 ⅱ 유전자의 프로모터 및 이를 이용한유용단백질의 생산 방법 |
ATE384790T1 (de) * | 2002-11-04 | 2008-02-15 | Cho A Pharm Co Ltd | Uroplakin-ii-promotor aus schwein und verfahren zur herstellung nützlicher proteine unter verwendung des promotors |
US20070061899A1 (en) * | 2005-04-13 | 2007-03-15 | The Trustees Of Columbia University In The City Of New York | Transgenic mammal with constitutive, tissue-specific cytokine expression and use as a cancer model |
TWI635098B (zh) | 2013-02-01 | 2018-09-11 | 再生元醫藥公司 | 含嵌合恆定區之抗體 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4873191A (en) * | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
WO1994005782A1 (en) * | 1992-09-10 | 1994-03-17 | Trustees Of Tufts College | In vivo production of transgenic organ by introducing the transgene via lumen |
-
1995
- 1995-06-05 US US08/464,961 patent/US5824543A/en not_active Expired - Lifetime
-
1996
- 1996-05-31 EP EP96916890A patent/EP0837931B1/de not_active Expired - Lifetime
- 1996-05-31 AU AU59615/96A patent/AU5961596A/en not_active Abandoned
- 1996-05-31 CA CA002221453A patent/CA2221453A1/en not_active Abandoned
- 1996-05-31 DE DE69623122T patent/DE69623122T2/de not_active Expired - Fee Related
- 1996-05-31 WO PCT/US1996/008233 patent/WO1996039494A1/en active IP Right Grant
- 1996-05-31 AT AT96916890T patent/ATE222601T1/de not_active IP Right Cessation
-
1997
- 1997-08-08 US US08/907,800 patent/US6001646A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0837931A4 (de) | 1999-06-02 |
WO1996039494A1 (en) | 1996-12-12 |
EP0837931B1 (de) | 2002-08-21 |
EP0837931A1 (de) | 1998-04-29 |
AU5961596A (en) | 1996-12-24 |
US5824543A (en) | 1998-10-20 |
DE69623122T2 (de) | 2002-12-12 |
CA2221453A1 (en) | 1996-12-12 |
US6001646A (en) | 1999-12-14 |
DE69623122D1 (de) | 2002-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69623122D1 (de) | Methode zur expression in und isolation von biologisch aktiven molekülen aus urin | |
DE69432540D1 (de) | Verfahren zur Herstellung von Nucleinsäuren aus einer biologischen Probe bei niedrigem pH und unter Verwendung einer Säureprotease | |
ATE443437T1 (de) | Modifiziertes bacillus thuringiensis gen zur kontrolle von lepidoptera in pflanzen | |
DE69535389D1 (de) | Methode zur selektion hoch-exprimierender wirtszellen | |
DE69031237D1 (de) | Verfahren zur Reinigung von Nukleinsäuren | |
DE69132098D1 (de) | Verfahren zur amplifikation von nukleinsäuren | |
DK257984A (da) | Fremgangsmaade til fremstilling af en rekombinant baculovirus-udtrykkelsesvektor | |
DE69634043D1 (de) | Zirkuläres dna molekül mit einem abhängigen replikationsursprung, seine herstellungsverfahren und seine verwendung in der gentherapie | |
DE69838521D1 (de) | Methode zur Erhöhung der Konzentration von Nucleinsäuremolekülen | |
DE69331550T2 (de) | Klonierung und expression von biologisch aktiver alpha-galaktosidase a | |
FI880017A (fi) | Menetelmä haiman erittämän trypsiini-inhibiittorivarianttien valmistamiseksi ja menetelmässä käytettävä DNA, vektori ja isäntäsolu | |
DE69637579D1 (de) | Methode zur Amplifizierung von Nukleinsäure und entsprechende Regenzien dafür | |
DE69637154D1 (de) | Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins | |
DE59708441D1 (de) | Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten | |
DE69430975T2 (de) | Verfahren zur Herstellung von Proteinen | |
DE69029663D1 (de) | Verfahren zur endoproteolytischen bearbeitung von (vorläufer)proteinen und zur (mikro)biologischen herstellung | |
DE68926025D1 (de) | Methode zur Herstellung von alpha-Amylase hemmenden Substanzen aus Weizen | |
DE60038565D1 (de) | Verfahren zur herstellung von ubiquinon-10 | |
DE3782560D1 (de) | Hefestaemme zur expression fremder gene. | |
EP0592685A4 (de) | Planze resistent gegen mindestens zwei viren und dessen preparation. | |
DE60030726D1 (de) | Methode zur Herstellung von Mikropartikeln enthaltend biologisches Material | |
DE60318882D1 (de) | Uroplakin-ii-promotor aus schwein und verfahren zur herstellung nützlicher proteine unter verwendung des promotors | |
ATE118816T1 (de) | Verfahren zur herstellung von acci- restriktionsendonuklease und -methylase. | |
EP1074619A3 (de) | Promoter für Neuropeptide FF und Anwendung davon für Therapie und Nachweis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |